NCT01261247 2022-05-24Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaMayo ClinicPhase 2 Completed41 enrolled 8 charts
NCT01383447 2017-08-08Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 1/2 Terminated2 enrolled 4 charts
NCT01075425 2016-04-15Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic SyndromeVirginia Commonwealth UniversityPhase 1 Completed41 enrolled
NCT01658319 2015-08-13Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic MalignanciesCase Comprehensive Cancer CenterPhase 1 Completed20 enrolled
NCT01016990 2014-01-10Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI)Phase 2 Unknown52 enrolled